The rat osteocalcin fibroblast growth factor (FGF)-responsive element: An okadaic acid-sensitive, FGF-selective transcriptional response motif

Molecular Endocrinology

Volumn 10, Issue 8, 1996, Pages 1029-1040

  Newberry, Elizabeth Patton ^a   Boudreaux, Jeanne M ^a   Towler, Dwight A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; CALYCULIN A; COLLAGENASE; CYCLIC AMP; DNA; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR; LUCIFERASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; OKADAIC ACID; OSTEOCALCIN; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA; VANADIC ACID; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE RESPONSIVE ELEMENT; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; CELL LINE; DNA; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; GROWTH SUBSTANCES; MICE; OKADAIC ACID; OSTEOCALCIN; OXAZOLES; PHOSPHOPROTEIN PHOSPHATASE; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, FIBROBLAST GROWTH FACTOR; VANADATES;

ANIMALIA;

EID: 0029761046     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.10.8.1029     Document Type: Article

References (66)

1. Burgess WH, Maciag T 1989 The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575-606
2. Doniach T 1995 Basic FGF as an inducer of anteroposterior neural pattern. Cell 83:1067-1070
3. Friesel RE, Maciag T 1995 Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 9:919-925
4. Niswander L, Tickle C, Vogel A, Booth I, Martin GR 1993 FGF-4 replaces the apical ectodermal ridge and directs outgrowth and patterning of the limb. Cell 75:579-587
5. Globus RK, Patterson-Buckendahl P, Gospodarowicz D 1988 Regulation of bovine bone cell proliferation by fibroblast and transforming growth factor beta. Endocrinology 123:98-105
6. Long MW, Robin JA, Ashcraft EA, Mann KG 1995 Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 95:881-887
7. Pitaru S, Kotev-Emeth S, Noff D, Kaffuler S, Savion N 1993 Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: Enhanced development of mineralized bone-like tissue in culture. J Bone Miner Res 8:919-929
8. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ et al. 1994 A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet 8:269-274
9. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S 1994 Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet 8:98-103
10. Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ Thanatophoric dysplasia (types I, II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet 9:321-328
11. Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ 1994 Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342
12. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM 1996 Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet 12:390-397
13. Neilson KM, Friesel RE 1995 Constitutive activation of fibroblast growth factor-2 by a point mutation associated with Crouzon Syndrome. J Biol Chem 270:26037-26040
14. Nakamura T, Hanada K, Tamura M, Shibanushi T, Nigi H, Tagawa M, Fukumoto S, Matsumoto T 1995 Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136:1276-1284
15. Mayarhar H, Ito T, Nagai H, Miyajima H, Tsukuda R, Taketomi S, Mizoguchi J, Kato K 1993 In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9:73-80
16. Mazue G, Bertolero F, Garofano L, Brughera M, Carminati P 1992 Experience with the preclinical assessment of basic fibroblast growth factor (bFGF). Toxicol Lett 64-65:Spec No:329-338
17. Ware JL 1993 Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer cells. Cancer Metastasis Rev 12:287-301
18. Hunter T 1995 Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling. Cell 80:225-236
19. Johnson DE, Williams LT 1993 Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41
20. Huang J, Mohammadi M, Rodrigues GA, Schlessinger J 1995 Reduced activation of raf-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. J Biol Chem 270:5065-5072
21. Peter KG, Marie J, Wilson E, Ives HE, Escobedo J, Del Rosario M, Mirda D, Williams LT 1992 Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca+2 flux but not mitogenesis. Nature 358:678-681
22. Mahammadi M, Dionne CA, Li W, Li N, Spivak T, Honegger AM, Jaye M, Schlessinger J 1992 Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 358:681-684
23. Burgering BM Th, Coffer PJ 1995 Protein kinase B (c-Akt) in phosphatidylinositol-3OH kinase signal transduction. Nature 376:599-602
24. Hill CS, Treisman R 1995 Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80:199-211
25. Hunter T, Karin M 1992 The regulation of transcription by phosphorylation. Cell 70:375-387
26. Kudla A, John ML, Bowen-Pope DF, Rainish B, Olwin BB 1995 A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways. Mol Cell Biol 15:3238-3246
27. Klint P, Kanda S, Laesson-Welsh L 1995 Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells. J Biol Chem 270:23337-23344
28. Boudreaux JM, Towler DA 1996 Synergistic induction of osteocalcin gene expression: Identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter. J Biol Chem 271:7508-7515
29. Olwin BB, Hauschka SD 1989 Cell type and tissue distribution of the fibroblast growth factor receptors. J Cell Biochem 39:443-454
30. Towler DA, Rodan GA 1995 Identification of a rat osteocalcin promoters 3′, 5′-cyclic adenosine monophosphate response region containing two PuGGTCA steroid hormone receptor binding motifs. Endocrinology 136:1089-1096
31. Hurley MM, Abreu C, Harrison JR, Lichtler AC, Raisz LG, Kream BE 1993 Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J Biol Chem 268:5588-5593
32. Hurley MM, Marcello K, Abreu C, Brinckerhoff CE, Bowik CC, Hibbs MS 1995 Transcriptional regulation of the collagenase gene by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 214:331-339
33. Okazaki R, Ikeda K, Sakamoto A, Nakano T, Morimoto K, Kikuchi T, Urakawa K, Ogata E, Matsumodo T 1992 Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells. J Bone Miner Res 7:1149-1155
34. Kozawa O, Suzuki A, Watanabe Y, Shinoda J, Oiso Y Effect of platelet-derived growth factor on phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like cells. Endocrinology 136:4473-4478
35. Strong DD, Merriman HL, Landale EC, Baylink DJ, Mohan S 1994 The effects of the insulin-like growth factors and transforming growth factor beta on Jun proto-oncogene family in MC3T3-E1 cells. Calcif Tissue Int 55:311-315
36. Mccauley LK, Koh AJ, Beecher CA, Cui YQ, Decker JD, Franchesi RT 1995 Effects of differentiation and transforming growth factor beta(1) on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells. J Bone Miner Res 10:1243-1255
37. Patstone G, Pasquale EB, Maher PA 1992 Different members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chick embryo. Dev Biol 155:107-123
38. Inagaki M, Kawamoto S, Itoh H, Saitoh M, Hagiwara M, Takahashi J, Hidaka H 1986 Naphthalenesulfonamides as calmodulin antangonists and protein kinase inhibitors. Mol Pharmacol 29:577-581
39. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y 1984 Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036-5041
40. Hidaka H, Hagiwara M, Chijiwa T 1990 Molecular pharmacology of protein kinases. Neurochem Res 15:431-434
41. Dobrowsky, RT, Kamibayashi C, Mumby MC, Hannun YA 1993 Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 268:15523-15530
42. Cohen P, Holmes CF, Tsukitani Y 1990 Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem Sci 15:98-102
43. Chen MX, McPartlin AE, Brown L, Chen YH, Barker HM, Cohen PTW 1994 A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. EMBO J 13:4278-4290
44. Brewis ND, Street AJ, Prescott AR, Cohen PTW 1993 PPX, a novel protein serine/threonine phosphatase localized to centrosomes. EMBO J 12:987-996
45. Sudbeck BD, Parks WC, Welgus HG, Pentland AP 1994 Collagen-stimulated induction of keratinocyte collagenase is mediated via tyrosine kinase and protein kinase C activities. J Biol Chem 269:30022-30029
46. Okamura K, Sato Y, Matsuda T, Hamanaka R, Ono M, Kohno K, Kuwano M 1991 Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells. J Biol Chem 266: 19162-19165
47. Kennedy SH, Qin H, Lin L, Tan EM 1995 Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells. Am J Pathol 146:764-771
48. Varghese S, Ramsby ML, Jeffrey JJ, Canalis E 1995 Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells. Endocrinology 136:2156-2162
49. Chen J, Shapiro HS, Wrana JL, Reimers S, Heersche JNM, Sodek J 1991 Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization. Matrix 11:133-143
50. Gack S, Vallon R, Schmidt J, Grigoriadis A, Tuckermann J, Schenkel J, Weiher H, Wagner EF, Angel P 1995 Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ 6:759-767
51. Glowacki J, Lian L 1987 Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deficient bone implants. Cell Differ 21:247-254
52. Chenu C, Colucci S, Grano M, Zigrino P, Barattolo R, Zambonin G, Baldini N, Vergnaud P, Delmas PD, Zallone AZ 1994 Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol 127:1149-1158
53. Rodan SB, Wesolowski G, Yoon K, Rodan GA 1989 Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J Biol Chem 264:19934-19941
54. Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SG, Green MR, Goodmna RH 1994 Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223-226
55. Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M, Tommerup N, van Ommen GJ, Goodman RH, Peters DJ, Breuning MH 1995 Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376:348-351
56. Li L, Zhou J, James G, Heller-Harrison, Czech MP, Olson EN 1992 FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71:1181-1194
57. Kim S-J, Kim KY, Tapscott SJ, Winokur TS, Park K, Fujiki H, Weintraub H, Roberts AB 1992 Inhibition of protein phosphatases blocks myogenesis by first altering MyoD binding activity. J Biol Chem 267:15140-15145
58. Gillespie LL, Paterno GD, Mahadevan LC, Slack JM 1992 Intracellular signaling pathways involved in mesoderm induction by FGF. Mech Dev 38:99-107
59. Wu YY, Bradshaw RA 1993 Effect of nerve growth factor and fibroblast growth factor on PC12 cells: inhibition by orthovanadate. J Cell Biol 121:409-422
60. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: Transient vs. sustained extracellular signal-regulated kinase activation. Cell 80:179-185
61. Mauro Lj, Olmsted EA, Davis AR, Dixon JE 1996 PTH regulates the expression of the receptor protein tyrosine phosphatase, OST-PTP, in rat osteoblast-like cells. Endocrinology 137:925-933
62. Heldin C-H 1995 Dimerization of cell surface receptors in signal transduction. Cell 80:213-223
63. Schedlich LJ, Flanagan JL, Crofts LA, Gillies SA, Goldberg DA, Morrison NA, Eisman JA 1994 Transcriptional activation of the human osteocalcin gene by basic fibroblast growth factor. J Bone Miner Res 9:143-152
64. Towler DA, Bennett CD, Rodan GA 1994 Activity of the rat osteocalcin promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs. Mol Endocrinol 8:614-624
65. Kou K, Mittanck DW, Fu C, Rotwein P 1995 Structure and function of the mouse insulin-like growth factor binding protein 5 gene promoter. DNA Cell Biol 14:241-249
66. Peterson GL 1977 A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346-356